Recent strides in stem cell research have led to the development of organ-specific tissue from stem cells, particularly cerebral brain organoids. These miniature 3D cultures, derived from adult human blood, mimic the complexity of actual organs. They provide a valuable model for studying neurodevelopmental conditions like epilepsy. Although their current use in epilepsy research is limited, notable references in PubMed highlight their potential.

Ongoing advancements in organoid technology ensure reproducibility. Additionally, personalized medicine holds promise by creating organoids directly from affected individuals for drug testing, though automation is key for scalability (Reference: Kelava and Lancaster, 2016).